Your browser doesn't support javascript.
loading
Phase 1 Study of the Combination of Escalated Total Marrow Irradiation Using Helical Tomotherapy and Fixed High-Dose Melphalan (140 mg/m²) Followed by Autologous Stem Cell Transplantation at First Relapse in Multiple Myeloma.
Cailleteau, Axel; Maingon, Philippe; Choquet, Sylvain; Bourdais, Rémi; Antoni, Delphine; Lioure, Bruno; Hulin, Cyrille; Batard, Stéphanie; Llagostera, Camille; Guimas, Valentine; Touzeau, Cyrille; Moreau, Philippe; Mahé, Marc-André; Supiot, Stéphane.
Afiliação
  • Cailleteau A; Department of Radiation Oncology, Institut de Cancérologie de l'Ouest, Nantes, St-Herblain, France. Electronic address: axel.cailleteau@ico.unicancer.fr.
  • Maingon P; Department of Radiation Oncology, Pitié-Salpêtrière, Paris, France.
  • Choquet S; Department of Hematology, Pitié-Salpêtrière, Paris, France.
  • Bourdais R; Department of Radiation Oncology, Pitié-Salpêtrière, Paris, France.
  • Antoni D; Department of Radiation Oncology, ICANS, Strasbourg, France.
  • Lioure B; Department of Hematology, ICANS, Strasbourg, France.
  • Hulin C; Department of Hematology, Hôpital Haut Lévêque, University Hospital Bordeaux, Bordeaux, France.
  • Batard S; Department of Radiation Oncology, Institut Bergonie, Bordeaux, France.
  • Llagostera C; Physics Unit, Institut de Cancérologie de l'Ouest, Nantes, St-Herblain, France.
  • Guimas V; Department of Radiation Oncology, Institut de Cancérologie de l'Ouest, Nantes, St-Herblain, France.
  • Touzeau C; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France; Nantes Université, INSERM, CNRS, Université d'Angers, CRCI2NA, Nantes, France; Site de recherche intégrée sur le cancer (SIRIC), ILIAD INCA-DGOS-Inserm U12558, Nantes, France.
  • Moreau P; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France; Site de recherche intégrée sur le cancer (SIRIC), ILIAD INCA-DGOS-Inserm U12558, Nantes, France; Nantes Université, INSERM, CNRS, Université d'Angers, CRCI2NA, Nantes, France.
  • Mahé MA; Department of Radiation Oncology, Centre François Baclesse, Caen, France.
  • Supiot S; Department of Radiation Oncology, Institut de Cancérologie de l'Ouest, Nantes, St-Herblain, France; Centre de Recherche en Cancérologie Nantes Angers, UMR 1232 Inserm - 6299 CNRS, Nantes, France.
Int J Radiat Oncol Biol Phys ; 115(3): 677-685, 2023 03 01.
Article em En | MEDLINE | ID: mdl-36174802
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mucosite / Radioterapia de Intensidade Modulada / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Int J Radiat Oncol Biol Phys Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mucosite / Radioterapia de Intensidade Modulada / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Int J Radiat Oncol Biol Phys Ano de publicação: 2023 Tipo de documento: Article